# BioCritica

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/biocritica

- Industry: Biotechnology
- Headquarters: Indianapolis, US
- Website: www.biocritica.com
- Total disclosed funding: $25M
- Latest round: Series A (May 26, 2011)
- Investors on record: 1

## About

BioCritica is a company focused on providing specialized solutions in critical care medicine, aiming to enhance patient outcomes through innovative medical products and services.BioCritica, founded in 2011 in Indianapolis, US, specializes in critical care solutions. The company has secured a total of 3 deals and recently raised USD 25.00 mn in a Series A funding round led by Care Capital, which brings the total amount raised to USD 25.00 mn and current valuation to USD 51.51 mn.BioCritica provides a range of innovative medical products specifically designed for critical care settings. These products aim to enhance patient monitoring and management, ensuring improved outcomes in high-stakes medical environments. The company targets healthcare facilities globally, including hospitals in North America, Europe, and select regions in Asia, catering to both small and large institutions.BioCritica generates revenue through a direct sales model, offering its medical products to healthcare providers. The revenue structure is primarily based on one-time purchases and ongoing service agreements, designed to meet the needs of various healthcare settings. BioCritica ensures competitive pricing for its flagship products, which are aimed at maximizing accessibility for a broad range of healthcare establishments.Unfortunately, BioCritica has gone out of business.

## Funding rounds

- Series A, May 26, 2011, $25M — Care Capital

## Investors

- Care Capital (https://capitalatlas.ai/funds/care-capital) — Series A